HYPERCHOLESTEROLEMIA
Clinical trials for HYPERCHOLESTEROLEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERCHOLESTEROLEMIA trials appear
Sign up with your email to follow new studies for HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene-Editing heart therapy tracked for 15 years
Disease control ENROLLING_BY_INVITATIONThis study follows about 116 people who received an experimental gene-editing therapy for heart disease or high cholesterol. Researchers will monitor participants for 15 years to check for side effects and measure changes in cholesterol levels. The goal is to understand the long-…
Matched conditions: HYPERCHOLESTEROLEMIA
Sponsor: Verve Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 02:56 UTC
-
Cancer survivors get a new care team to tackle heart risks
Disease control OngoingThis study tests a new way to help cancer survivors manage other health problems like high blood pressure, diabetes, and high cholesterol. About 800 adults with certain cancers and at least one heart-related condition will be enrolled. Their primary care doctors will work more cl…
Matched conditions: HYPERCHOLESTEROLEMIA
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated May 17, 2026 02:55 UTC
-
New shot could slash bad cholesterol in High-Risk asian patients
Disease control OngoingThis study tests a drug called inclisiran in about 345 Asian patients with high cholesterol and heart disease or high risk for it. The drug is given as an injection alongside standard statin therapy. The main goal is to see if it safely lowers 'bad' LDL cholesterol more than a pl…
Matched conditions: HYPERCHOLESTEROLEMIA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 02:55 UTC
-
New study aims to help heart patients hit cholesterol targets
Disease control ENROLLING_BY_INVITATIONThis study looks at different methods to help people with high cholesterol and heart disease get their LDL ("bad") cholesterol to recommended levels. About 300 adults with or at high risk for artery disease will take part. Researchers will compare approaches to improve use of cho…
Matched conditions: HYPERCHOLESTEROLEMIA
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 17, 2026 02:53 UTC
-
New combo pill takes aim at stubborn high cholesterol
Disease control OngoingThis study tested a combination of two cholesterol-lowering medicines (Pitavastatin and Ezetimibe) in 88 adults with high cholesterol and high triglycerides. The goal was to see if the combo works better than Pitavastatin alone at reducing LDL (bad) cholesterol over 8 weeks, with…
Matched conditions: HYPERCHOLESTEROLEMIA
Phase: PHASE4 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated May 17, 2026 02:53 UTC
-
New cholesterol drug shows promise in Long-Term trial
Disease control OngoingThis study looks at the long-term safety and effectiveness of the drug MK-0616 (enlicitide decanoate) in adults with high cholesterol. It includes 3000 people who already completed an earlier study with the same drug. The main goals are to track side effects and see how well the …
Matched conditions: HYPERCHOLESTEROLEMIA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Website may help patients overcome statin side effects
Knowledge-focused OngoingThis study tests whether a 30-minute educational website helps people who stopped taking statins due to muscle symptoms make informed decisions about restarting the medication. About 816 participants will either use the website or receive usual care. Researchers will track how ma…
Matched conditions: HYPERCHOLESTEROLEMIA
Phase: NA • Sponsor: University of Utah • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC
-
New cholesterol drug under Real-World microscope
Knowledge-focused OngoingThis study follows 5,000 adults with high cholesterol who are taking bempedoic acid (alone or with ezetimibe) in everyday medical practice. Researchers will track how well the drug lowers cholesterol, any side effects, and heart-related events over one year or more. The goal is t…
Matched conditions: HYPERCHOLESTEROLEMIA
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC
-
Keto diet heart check: study probes Long-Term risks for epilepsy patients
Knowledge-focused OngoingThis study looks at how ketogenic diets (like the modified Atkins diet) impact heart health in adults with epilepsy. Researchers will measure cholesterol, blood pressure, weight, and artery thickness over 12 months. About 105 adults aged 18 and older who are already on or startin…
Matched conditions: HYPERCHOLESTEROLEMIA
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC
-
Hidden heart risk? hospital staff screened for little-known cholesterol
Knowledge-focused OngoingThis study checks how often hospital staff have high levels of a type of cholesterol called Lp(a), which can raise the risk of heart disease. About 2,800 healthcare workers and their family members will give blood samples. The goal is to see how common this condition is in differ…
Matched conditions: HYPERCHOLESTEROLEMIA
Sponsor: Changi General Hospital • Aim: Knowledge-focused
Last updated May 07, 2026 18:39 UTC